RankingsPricing
  1. JP-listed companies
  2. BrightPath Biotherapeutics Co., Ltd.
  3. Financials
  4. Pretax margin (%)

BrightPath Biotherapeutics Co., Ltd.【JP:4594】

Market cap
¥6.3B
P/E ratio
-5.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 2025-101,313.2-93.71%
Mar 31, 2024-1,609,623.6+5666.70%
Mar 31, 2023-27,912.4+190.21%
Mar 31, 2022-9,618-86.15%
Mar 31, 2021-69,434.3+330.16%
Mar 31, 2020-16,141.6+1398.72%
Mar 31, 2019-1,077+142.62%
Mar 31, 2018-443.9+110.56%
Mar 31, 2017-210.8+74.64%
Mar 31, 2016-120.7+139.87%
Mar 31, 2015-50.3-2553.76%
Mar 31, 20142.1-95.78%
Mar 31, 201348.6+218.01%
Mar 31, 201215.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)